TUMOR PROGRESSION AND CHEMORESISTANCE IN OVARIAN CARCINOMA EFFUSIONS

被引：0
|
作者：
Davidson, B. [1 ]
机构：
[1] Oslo Univ Hosp, Norwegian Radium Hosp, Oslo, Norway
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma
    Li Yuan
    Shibing Li
    Qiuyan Chen
    Tianliang Xia
    Donghua Luo
    Liangji Li
    Sailan Liu
    Shanshan Guo
    Liting Liu
    Chaochao Du
    Guodong Jia
    Xiaoyun Li
    Zijian Lu
    Zhenchong Yang
    Huanliang Liu
    Haiqiang Mai
    Linquan Tang
    [J]. Cell Death & Differentiation, 2022, 29 : 1513 - 1527
  • [32] ROR1 is associated with ovarian cancer progression and chemoresistance.
    Liu, Dongli
    John, Miya
    Henry, Claire E.
    Christie, Elizabeth L.
    Bowtell, David D. L.
    Tang, Kristina
    Heinzelmann-Schwarz, Viola
    Kennedy, Catherine
    Boros, Jessica
    DeFazio, Anna
    Ford, Caroline E.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (13) : 59 - 60
  • [33] The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer
    Yang, Gong
    Xiao, Xue
    Rosen, Daniel G.
    Cheng, Xi
    Wu, Xiaohua
    Chang, Bin
    Liu, Guangzhi
    Xue, Fengxia
    Mercado-Uribe, Imelda
    Chiao, Paul
    Du, Xiang
    Liu, Jinsong
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2181 - 2194
  • [34] Ovarian Clear Cell Carcinoma and Serous Carcinoma: Immunohistochemical Profile and Correlation with Chemoresistance
    Kwak, H. A.
    Fadare, O.
    Quick, C. M.
    Lengvel, E.
    Montag, A.
    Gwin, K.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 291A - 291A
  • [35] Ovarian Clear Cell Carcinoma and Serous Carcinoma: Immunohistochemical Profile and Correlation with Chemoresistance
    Kwak, H. A.
    Fadare, O.
    Quick, C. M.
    Lengyel, E.
    Montag, A.
    Gwin, K.
    [J]. MODERN PATHOLOGY, 2014, 27 : 291A - 291A
  • [36] Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays
    McAlpine, J. N.
    Eisenkop, S. M.
    Spirtos, N. M.
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : 360 - 364
  • [37] Tumor Stem-Cells and the Biology of Chemoresistance in Ovarian Cancer
    Hatina, J.
    Reimer, D.
    Sopper, S.
    Boesch, M.
    Martowicz, A.
    Roessler, J.
    Wiedemair, A.
    Wolf, D.
    Zeimet, A. G.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (04)
  • [38] Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma
    Bonneau, Claire
    Rouzier, Roman
    Geyl, Caroline
    Cortez, Annie
    Castela, Mathieu
    Lis, Raphael
    Darai, Emile
    Touboul, Cyril
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 136 (01) : 112 - 120
  • [39] Identification of mediators of chemoresistance in a heterogeneous tumor model of ovarian cancer
    Croft, K. M.
    Cornelison, R.
    Llaneza, D. C.
    Landen, C. N., Jr.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 86 - 86
  • [40] Cadherin expression in ovarian carcinoma and malignant mesothelioma cell effusions
    Sivertsen, Stine
    Berner, Aasmund
    Michael, Claire W.
    Bedrossian, Carlos
    Davidson, Ben
    [J]. ACTA CYTOLOGICA, 2006, 50 (06) : 603 - 607
12345